More About Moderna, Gilead and Forty Seven

Moderna Therapeutics
Among all the firms announcing their interest in working towards designing and producing a preventive vaccine for COVID-19 only Moderna (MRNA) has accomplished that job and delivered it to the health authorities to decide upon the next step.

Moderna’s stock soared. The stock did not go up in expectation of the millions . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.